These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8209057)

  • 1. Bronchodilator response to nebulized salbutamol in elderly patients with stable chronic airflow limitation.
    Geraghty R; Foster C; Black D; Roe S
    Respir Med; 1993 Jul; 87(5):375-8. PubMed ID: 8209057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
    Cazzola M; Di Perna F; Noschese P; Vinciguerra A; Calderaro F; Girbino G; Matera MG
    Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease.
    Hadcroft J; Calverley PM
    Thorax; 2001 Sep; 56(9):713-20. PubMed ID: 11514693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
    Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM
    Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute bronchodilator trials in chronic obstructive pulmonary disease.
    Nisar M; Earis JE; Pearson MG; Calverley PM
    Am Rev Respir Dis; 1992 Sep; 146(3):555-9. PubMed ID: 1387772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation.
    Jenkins SC; Heaton RW; Fulton TJ; Moxham J
    Chest; 1987 Jun; 91(6):804-7. PubMed ID: 3556051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulized wet aerosol treatment in emergency department--is it essential? Comparison with large spacer device for metered-dose inhaler.
    Mandelberg A; Chen E; Noviski N; Priel IE
    Chest; 1997 Dec; 112(6):1501-5. PubMed ID: 9404745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease.
    Thomas P; Pugsley JA; Stewart JH
    Chest; 1992 Jan; 101(1):160-5. PubMed ID: 1729064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of FEV6, FVC, and FET to inhaled bronchodilator in the adult general population.
    Kainu A; Lindqvist A; Sarna S; Lundbäck B; Sovijärvi A
    Respir Res; 2009 Jul; 10(1):71. PubMed ID: 19638220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease.
    Hay JG; Stone P; Carter J; Church S; Eyre-Brook A; Pearson MG; Woodcock AA; Calverley PM
    Eur Respir J; 1992 Jun; 5(6):659-64. PubMed ID: 1628722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease.
    Grove A; Lipworth BJ; Reid P; Smith RP; Ramage L; Ingram CG; Jenkins RJ; Winter JH; Dhillon DP
    Thorax; 1996 Jul; 51(7):689-93. PubMed ID: 8882074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
    Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation.
    Guyatt GH; Townsend M; Nogradi S; Pugsley SO; Keller JL; Newhouse MT
    Arch Intern Med; 1988 Sep; 148(9):1949-52. PubMed ID: 3046537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of two doses of salbutamol nebulized at 4 and 8 litres per minute in patients with chronic asthma.
    Douglas JG; Leslie MJ; Crompton GK; Grant IW
    Br J Dis Chest; 1986 Jan; 80(1):55-8. PubMed ID: 3947525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.
    Wempe JB; Postma DS; Breederveld N; Kort E; van der Mark TW; Koëter GH
    Thorax; 1992 Aug; 47(8):616-21. PubMed ID: 1412119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Response to inhaled bronchodilators in chronic airway obstruction].
    Holten K
    Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ipratropium bromide and albuterol in chronic obstructive pulmonary disease: a three-center study.
    Braun SR; Levy SF
    Am J Med; 1991 Oct; 91(4A):28S-32S. PubMed ID: 1835292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.